Study of Comparing of With and Without Sequential Therapy of S-1
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The goal of this single arm clinical trial is to learn about sequential S-1 adjuvant therapy
in patient wich locally advanced gastric cancer. The main question it aims to answer is:
• The efficacy and safety of S-1 adjuvant therapy, following D2 radical surgery and
DS(Docetaxel + S-1) adjuvant chemotherapy.
All patients with locally advanced gastric cancer will received D2 radical surgery, 6 cycles
of DS chemotherapy, and sequential S-1 chemotherapy up to 1 year postoperation.